TownSquare Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.66M | Buy |
30,427
+894
| +3% | +$192K | 1.41% | 14 |
|
|
2026
Q1 | $6.42M | Sell |
29,533
-1,012
| -3% | -$224K | 1.45% | 16 |
|
|
2025
Q4 | $6.98M | Sell |
30,545
-5,838
| -16% | -$1.33M | 1.56% | 13 |
|
|
2025
Q3 | $8.42M | Sell |
36,383
-7,540
| -17% | -$1.54M | 1.27% | 16 |
|
|
2025
Q2 | $8.15M | Sell |
43,923
-141,126
| -76% | -$26.2M | 0.79% | 24 |
|
|
2025
Q1 | $38.8M | Buy |
185,049
+26,989
| +17% | +$5.25M | 0.41% | 46 |
|
|
2024
Q4 | $28.1M | Buy |
158,060
+17,377
| +12% | +$3.19M | 0.32% | 67 |
|
|
2024
Q3 | $27.8M | Buy |
140,683
+2,368
| +2% | +$442K | 0.33% | 62 |
|
|
2024
Q2 | $23.7M | Buy |
138,315
+36,119
| +35% | +$5.98M | 0.32% | 67 |
|
|
2024
Q1 | $18.6M | Sell |
102,196
-2,791
| -3% | -$481K | 0.27% | 83 |
|
|
2023
Q4 | $16.3M | Sell |
104,987
-8,255
| -7% | -$1.2M | 0.28% | 77 |
|
|
2023
Q3 | $16.9M | Sell |
113,242
-4,508
| -4% | -$662K | 0.31% | 72 |
|
|
2023
Q2 | $15.9M | Buy |
117,750
+17,223
| +17% | +$2.53M | 0.29% | 78 |
|
|
2023
Q1 | $16M | Sell |
100,527
-5,385
| -5% | -$823K | 0.35% | 68 |
|
|
2022
Q4 | $17.1M | Buy |
105,912
+41,263
| +64% | +$6.33M | 0.42% | 58 |
|
|
2022
Q3 | $8.68M | Buy |
64,649
+2,211
| +4% | +$317K | 0.25% | 80 |
|
|
2022
Q2 | $9.56M | Buy |
62,438
+3,761
| +6% | +$575K | 0.27% | 72 |
|
|
2022
Q1 | $9.51M | Buy |
58,677
+6,951
| +13% | +$1.01M | 0.24% | 77 |
|
|
2021
Q4 | $7M | Sell |
51,726
-877
| -2% | -$104K | 0.18% | 99 |
|
|
2021
Q3 | $5.67M | Buy |
52,603
+7,330
| +16% | +$838K | 0.16% | 111 |
|
|
2021
Q2 | $5.24M | Buy |
45,273
+3,000
| +7% | +$338K | 0.17% | 106 |
|
|
2021
Q1 | $4.57M | Buy |
42,273
+234
| +0.6% | +$25K | 0.18% | 108 |
|
|
2020
Q4 | $4.5M | Buy |
42,039
+16,016
| +62% | +$1.54M | 0.2% | 101 |
|
|
2020
Q3 | $2.23M | Buy |
26,023
+665
| +3% | +$62.6K | 0.13% | 136 |
|
|
2020
Q2 | $2.48M | Sell |
25,358
-7,084
| -22% | -$624K | 0.17% | 112 |
|
|
2020
Q1 | $2.69M | Buy |
32,442
+3,271
| +11% | +$279K | 0.22% | 90 |
|
|
2019
Q4 | $2.58M | Sell |
29,171
-3,161
| -10% | -$262K | 0.21% | 92 |
|
|
2019
Q3 | $2.65M | Buy |
32,332
+1,427
| +5% | +$97.8K | 0.22% | 91 |
|
|
2019
Q2 | $2.02M | Sell |
30,905
-9,120
| -23% | -$717K | 0.19% | 95 |
|
|
2019
Q1 | $3.23M | Buy |
40,025
+15,331
| +62% | +$1.25M | 0.25% | 84 |
|
|
2018
Q4 | $1.97M | Buy |
+24,694
| New | +$2.17M | 0.26% | 79 |
|
Other funds holding ABBV
TownSquare Capital's ABBV Position: Q2 2026 in Review
TownSquare Capital increased its AbbVie (ABBV) stake by 3% in Q2 2026, buying an estimated $192K and bringing the position to 30,427 shares worth $7.66M. The position accounts for 1.41% of the portfolio, ranked #14.
TownSquare Capital first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $38.8M in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TownSquare Capital held 30,427 shares of AbbVie worth $7.66M as of Q2 2026.
- TownSquare Capital bought 894 AbbVie shares in Q2 2026, an estimated $192K.
- AbbVie made up 1.41% of TownSquare Capital's portfolio in Q2 2026, its #14 holding.
- TownSquare Capital first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- TownSquare Capital's AbbVie position peaked at $38.8M in Q1 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.